LEUCINE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 131.0 | 0.4 | 2 | 2 | 63.0 | 3 | 0.83 |
- CAS
- 61905
- UNII
- GMW67QNF9C
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 96 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02386267 | 2014-09-01 | L-leucine in Diamond Blackfan Anemia Patients | Phase 2 | Recruiting |
| NCT02038543 | 2013-09-01 | Hydroxyproline Influence on Oxalate Metabolism | Phase 1/Phase 2 | Recruiting |
| NCT01362595 | 2013-06-01 | Therapeutic Use of the Amino Acid, Leucine in the Treatment of Transfusion - Dependent Diamond Blackfan Anemia Patients | Phase 1/Phase 2 | Recruiting |
| NCT01128244 | 2010-04-01 | Vitamin B6 Effects for Women Taking Birth Control Pills | Phase 2/Phase 3 | Completed |
| NCT00968344 | 2009-08-01 | Muscle Mass During Space Exploration | Phase 3 | Active, Not Recruiting |
| NCT00972582 | 2009-05-01 | Upper Limit of Leucine Intake in Adults | Phase 1 | Completed |
| NCT00643773 | 2008-05-01 | The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients | Phase 2/Phase 3 | Completed |
| NCT00807508 | 2007-01-01 | Leucine Supplementation in Elderly Men | Phase 1/Phase 2 | Completed |
| NCT00429416 | 2004-03-01 | Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation | Phase 1/Phase 2 | Completed |
| NCT00429039 | 2000-09-01 | A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation | Phase 2 | Terminated |